• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性骨质疏松症和代谢性骨病

Secondary Osteoporosis and Metabolic Bone Diseases.

作者信息

Sobh Mahmoud M, Abdalbary Mohamed, Elnagar Sherouk, Nagy Eman, Elshabrawy Nehal, Abdelsalam Mostafa, Asadipooya Kamyar, El-Husseini Amr

机构信息

Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt.

Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington, KY 40506, USA.

出版信息

J Clin Med. 2022 Apr 24;11(9):2382. doi: 10.3390/jcm11092382.

DOI:10.3390/jcm11092382
PMID:35566509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9102221/
Abstract

Fragility fracture is a worldwide problem and a main cause of disability and impaired quality of life. It is primarily caused by osteoporosis, characterized by impaired bone quantity and or quality. Proper diagnosis of osteoporosis is essential for prevention of fragility fractures. Osteoporosis can be primary in postmenopausal women because of estrogen deficiency. Secondary forms of osteoporosis are not uncommon in both men and women. Most systemic illnesses and organ dysfunction can lead to osteoporosis. The kidney plays a crucial role in maintaining physiological bone homeostasis by controlling minerals, electrolytes, acid-base, vitamin D and parathyroid function. Chronic kidney disease with its uremic milieu disturbs this balance, leading to renal osteodystrophy. Diabetes mellitus represents the most common secondary cause of osteoporosis. Thyroid and parathyroid disorders can dysregulate the osteoblast/osteoclast functions. Gastrointestinal disorders, malnutrition and malabsorption can result in mineral and vitamin D deficiencies and bone loss. Patients with chronic liver disease have a higher risk of fracture due to hepatic osteodystrophy. Proinflammatory cytokines in infectious, autoimmune, and hematological disorders can stimulate osteoclastogenesis, leading to osteoporosis. Moreover, drug-induced osteoporosis is not uncommon. In this review, we focus on causes, pathogenesis, and management of secondary osteoporosis.

摘要

脆性骨折是一个全球性问题,是导致残疾和生活质量受损的主要原因。它主要由骨质疏松症引起,其特征是骨量和/或骨质量受损。正确诊断骨质疏松症对于预防脆性骨折至关重要。由于雌激素缺乏,骨质疏松症在绝经后女性中可能是原发性的。继发性骨质疏松症在男性和女性中都并不罕见。大多数全身性疾病和器官功能障碍都可导致骨质疏松症。肾脏通过控制矿物质、电解质、酸碱平衡、维生素D和甲状旁腺功能,在维持生理骨稳态中发挥关键作用。慢性肾脏病及其尿毒症环境会扰乱这种平衡,导致肾性骨营养不良。糖尿病是骨质疏松症最常见的继发性病因。甲状腺和甲状旁腺疾病可使成骨细胞/破骨细胞功能失调。胃肠道疾病、营养不良和吸收不良可导致矿物质和维生素D缺乏及骨质流失。慢性肝病患者因肝性骨营养不良而发生骨折的风险更高。感染性、自身免疫性和血液学疾病中的促炎细胞因子可刺激破骨细胞生成,导致骨质疏松症。此外,药物性骨质疏松症也并不罕见。在本综述中,我们重点关注继发性骨质疏松症的病因、发病机制和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/65dd3c0e2586/jcm-11-02382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/3fa9ac86e74e/jcm-11-02382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/82a44af4d11a/jcm-11-02382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/e992e061e8e6/jcm-11-02382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/65dd3c0e2586/jcm-11-02382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/3fa9ac86e74e/jcm-11-02382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/82a44af4d11a/jcm-11-02382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/e992e061e8e6/jcm-11-02382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f643/9102221/65dd3c0e2586/jcm-11-02382-g004.jpg

相似文献

1
Secondary Osteoporosis and Metabolic Bone Diseases.继发性骨质疏松症和代谢性骨病
J Clin Med. 2022 Apr 24;11(9):2382. doi: 10.3390/jcm11092382.
2
Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.美国医疗保健研究与质量局(AHRQ)对低骨密度或骨质疏松症男性和女性预防骨折治疗的比较效果评价总结:2007年报告更新版
J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13. doi: 10.18553/jmcp.2012.18.s4-b.1.
3
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].慢性肾脏病患者骨质疏松症的诊断与治疗:奥地利骨与矿物质研究学会(ÖGKM)、奥地利物理与康复医学学会(ÖGPMR)及奥地利肾脏病学会(ÖGN)联合指南
Wien Med Wochenschr. 2023 Oct;173(13-14):299-318. doi: 10.1007/s10354-022-00989-0. Epub 2022 Dec 21.
4
Hepatic Osteodystrophy: A Global (Re)View of the Problem.肝性骨营养不良:对该问题的全球(再)审视
Acta Clin Croat. 2017 Sep;56(3):512-525. doi: 10.20471/acc.2017.56.03.19.
5
Management of osteoporosis in patients with chronic kidney disease.慢性肾脏病患者骨质疏松症的管理。
Osteoporos Int. 2022 Nov;33(11):2259-2274. doi: 10.1007/s00198-022-06462-3. Epub 2022 Jun 24.
6
Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.男性骨质疏松症。病因、发病机制、预防及管理的新见解。
Drugs Aging. 1998 Dec;13(6):421-34. doi: 10.2165/00002512-199813060-00002.
7
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
8
Chronic kidney disease and the skeleton.慢性肾脏病与骨骼
Bone Res. 2014 Dec 23;2:14044. doi: 10.1038/boneres.2014.44. eCollection 2014.
9
Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.骨质疏松症与慢性肾脏病-矿物质和骨异常(CKD-MBD):回归基础
Am J Kidney Dis. 2021 Oct;78(4):582-589. doi: 10.1053/j.ajkd.2020.12.024. Epub 2021 Mar 25.
10
Managing osteoporosis in ulcerative colitis: something new?溃疡性结肠炎患者骨质疏松症的管理:有新进展吗?
World J Gastroenterol. 2014 Oct 21;20(39):14087-98. doi: 10.3748/wjg.v20.i39.14087.

引用本文的文献

1
Research Progress on Icariin Promoting Bone Injury Repair and Regeneration.淫羊藿苷促进骨损伤修复与再生的研究进展
Pharmaceuticals (Basel). 2025 Aug 8;18(8):1174. doi: 10.3390/ph18081174.
2
Serum miR-146a as a diagnostic and predictive biomarker for osteoporosis and bisphosphonate treatment efficacy.血清miR-146a作为骨质疏松症的诊断和预测生物标志物以及双膦酸盐治疗效果的指标
Am J Transl Res. 2025 Jul 15;17(7):5320-5331. doi: 10.62347/JRIQ2431. eCollection 2025.
3
Serum LCAT as a Gender-Neutral Biomarker for Early Osteoporosis: A Multicenter Cohort Validation Study.

本文引用的文献

1
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.罗莫佐单抗治疗绝经后骨质疏松症合并轻中度慢性肾脏病女性患者的疗效和安全性。
J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20.
2
Tresca Stress Simulation of Metal-on-Metal Total Hip Arthroplasty during Normal Walking Activity.金属对金属全髋关节置换术在正常步行活动中的 Tresca 应力模拟
Materials (Basel). 2021 Dec 9;14(24):7554. doi: 10.3390/ma14247554.
3
Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4.
血清卵磷脂胆固醇酰基转移酶作为早期骨质疏松症的性别中性生物标志物:一项多中心队列验证研究。
Int J Gen Med. 2025 Jul 31;18:4131-4145. doi: 10.2147/IJGM.S536568. eCollection 2025.
4
Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures.阿仑膦酸钠在治疗严重骨折继发的骨质疏松症方面显示出显著的临床优势。
Am J Transl Res. 2025 Jun 15;17(6):4516-4523. doi: 10.62347/MFPV8667. eCollection 2025.
5
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study.高分化胃肠胰神经内分泌肿瘤中的脆性骨折:一项多中心回顾性研究的结果
J Neuroendocrinol. 2025 Sep;37(9):e70053. doi: 10.1111/jne.70053. Epub 2025 Jun 1.
6
Menopause and gastrointestinal health and disease.更年期与胃肠道健康及疾病
Nat Rev Gastroenterol Hepatol. 2025 May 23. doi: 10.1038/s41575-025-01075-7.
7
Canola Protein Hydrolysates Show Osteogenic Activity in MC3T3-E1 Cells.油菜籽蛋白水解物在MC3T3-E1细胞中显示出成骨活性。
J Food Sci. 2025 Apr;90(4):e70210. doi: 10.1111/1750-3841.70210.
8
Machine learning prediction of premature death from multimorbidity among people with inflammatory bowel disease: a population-based retrospective cohort study.炎症性肠病患者多种疾病导致过早死亡的机器学习预测:一项基于人群的回顾性队列研究。
CMAJ. 2025 Mar 24;197(11):E286-E297. doi: 10.1503/cmaj.241117.
9
Causal relationship between osteoporosis, bone mineral density, and osteonecrosis: a bidirectional two-sample Mendelian randomization study.骨质疏松症、骨密度和骨坏死之间的因果关系:一项双向双样本孟德尔随机化研究
J Transl Med. 2025 Feb 25;23(1):226. doi: 10.1186/s12967-024-06030-9.
10
Chronic alcohol consumption enhances the differentiation capacity of hematopoietic stem and progenitor cells into osteoclast precursors.长期饮酒会增强造血干细胞和祖细胞分化为破骨细胞前体的能力。
bioRxiv. 2025 Feb 8:2025.02.05.636743. doi: 10.1101/2025.02.05.636743.
硬化蛋白和 Dickkopf-1(DKK1)的循环水平与慢性肾脏病 3 期和 4 期患者的低骨转换相关。
Clin Kidney J. 2021 May 3;14(11):2401-2408. doi: 10.1093/ckj/sfab081. eCollection 2021 Nov.
4
Should patients with adult GH deficiency receive GH replacement?成年生长激素缺乏症患者是否应接受生长激素替代治疗?
Eur J Endocrinol. 2021 Nov 30;186(1):D1-D15. doi: 10.1530/EJE-21-0534.
5
Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy.非侵入性骨转换标志物在肾性骨营养不良中的诊断准确性
Am J Kidney Dis. 2022 May;79(5):667-676.e1. doi: 10.1053/j.ajkd.2021.07.027. Epub 2021 Oct 26.
6
Consensus on diagnosis and management of Cushing's disease: a guideline update.库欣病的诊断和治疗共识:指南更新。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20.
7
Assessment of bone quality with trabecular bone score in patients with inflammatory bowel disease.评估炎症性肠病患者的骨小梁骨评分的骨质量。
Sci Rep. 2021 Oct 13;11(1):20345. doi: 10.1038/s41598-021-99669-z.
8
Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions - Part II.慢性肾脏病患者的骨质量:当前概念与未来方向 - 第二部分
Kidney Dis (Basel). 2021 Sep;7(5):359-371. doi: 10.1159/000515542. Epub 2021 Apr 26.
9
Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study.先天性肾上腺皮质增生症患者骨折发病率增加:一项瑞典基于人群的全国队列研究。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e475-e486. doi: 10.1210/clinem/dgab712.
10
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus.2 型糖尿病性骨骼脆弱发病机制和治疗的最新进展。
Nat Rev Endocrinol. 2021 Nov;17(11):685-697. doi: 10.1038/s41574-021-00555-5. Epub 2021 Sep 13.